Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of 10 citing Sloand: Brief communication: successful treatment of pure red-cell aplasia with an anti-interleuk.... (0.08 sec) 

Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in …


TA Waldmann - Journal of Clinical Immunology, 2007 - Springer
Page 1. Journal of Clinical Immunology, Vol. 27, No. 1, January 2007 ( C
2007) DOI: 10.1007/s10875-006-9060-0 Anti-Tac (daclizumab ...
Cited by 35 - Related articles - BL Direct - All 4 versions

Daclizumab (anti-Tac, Zenapax) in the treatment of leukemia/lymphoma


TA Waldmann - Oncogene, 2007 - nature.com
Daclizumab (Zenapax) identifies the alpha subunit of the interleukin-2 (IL-2)
receptor and blocks the interaction of this cytokine with its growth factor
receptor. The scientific basis for the choice of the IL-2 receptor alpha ...
Cited by 19 - Related articles - BL Direct - All 3 versions

Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with …

- haematologica-thj.org
M Elimelakh, V Dayton, KS Park, AC … - haematologica, 2007 - haematologica-thj.org
Background and Objectives: Acquired red cell aplasia (RCA) is a rare disorder
and can be either idiopathic or associated with certain diseases, pregnancy, or
drugs. In exceptionally rare cases, it has been reported to co-exist with ...
Cited by 12 - Related articles - BL Direct - All 13 versions

Direct inhibition of CD40L expression can contribute to the clinical efficacy of daclizumab …

- hematologylibrary.org
JT Snyder, J Shen, H Azmi, J Hou, DH Fowler … - Blood, 2007 - bloodjournal.hematologylibrary.org
Humanized anti-CD25 antibodies (eg, daclizumab) have been successfully used to
treat several autoimmune diseases. Paradoxically, IL-2 blockade in mice can
induce autoimmunity. An interspecies difference in the relative ...
Cited by 10 - Related articles - BL Direct - All 5 versions

Serum soluble interleukin 2 receptor α in human cancer of adults and children: a review


E Bien, A Balcerska - Biomarkers, 2008 - informahealthcare.com
Cancer growth and development is associated with the stimulation of the innate
immune system, including enhanced interleukin 2 receptor (IL-2R) expression in
immune cells and its shedding into the circulation in a soluble form of ...
Cited by 13 - Related articles - BL Direct - All 4 versions

Pure red cell aplasia induced by erythropoiesis-stimulating agents

- asnjournals.org
C Pollock, DW Johnson, WH Horl, J Rossert, N … - Clinical Journal of the American Society of Nephrology, 2008 - Am Soc Nephrol
Pure red cell aplasia in patients who are treated for anemia of chronic kidney
disease with erythropoiesis-stimulating agents such as epoetin was first
reported in 1998. Although the incidence of pure red cell aplasia peaked in ...
Cited by 10 - Related articles - All 3 versions

Thrombotic Microangiopathy in Haematopoietic Stem Cell Transplantation: Diagnosis and …


CM Choi, AH Schmaier, MR Snell, HM … - Drugs, 2009 - ingentaconnect.com
Abstract Each year in the US, more than 10000 patients benefit from allogeneic
haematopoietic stem cell transplantation (HSCT), a modality that offers an
excellent chance of eradicating malignancy but confers a higher risk of ...
Cited by 1 - Related articles - All 5 versions

抗 CD25 单克隆抗体治疗重症再生障碍性贫血 1 例并文献复习


陈智超, 游泳, 李秋柏, 王红祥, 黎纬明, 刘新 … - 临床血液学杂志, 2007 - cqvip.com
首页; 期刊导航; 知识社区; 学者空间; 学术机构; 专题导读;
充值中心; 论文翻译. 登录 注册 帮助. 维普资讯 ...
Cited by 1 - Related articles - All 4 versions

52 例儿童特发性再生障碍性贫血的淋巴细胞免疫异常分析


陈纯, 魏菁, 李迎飞, 黄绍良, 方建培, 周敦华 … - 中国实验血液学杂志, 2008 - 万方数据资源系统
本研究评价儿童特发性再生障碍性贫血(IAA)发病时淋巴细胞免疫异常的特点,以探讨儿童特
发性再生障碍性贫血的免疫发病机制.应用流式细胞术检测患者发病时外周血中淋巴细胞表型 ...
Cited by 1 - Related articles - All 2 versions

[CITATION] Last literature review version 17.1: Thu Jan 01 00: 00: 00 GMT 2009| This topic last …


DP Ryan, H Mamon, RM Goldberg, CG Willett …
Related articles - All 2 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google